Literature DB >> 29868873

Etiology of Sepsis in Uganda Using a Quantitative Polymerase Chain Reaction-based TaqMan Array Card.

Christopher C Moore1, Shevin T Jacob2, Patrick Banura3, Jixian Zhang1, Suzanne Stroup1, David R Boulware4, W Michael Scheld1, Eric R Houpt1, Jie Liu1.   

Abstract

Background: Knowledge of causes of sepsis in sub-Saharan Africa is limited. A better understanding of the microbiology of bloodstream infections could improve outcomes.
Methods: We used a quantitative polymerase chain reaction (qPCR)-based TaqMan Array Card (TAC) to directly test for 43 targets from whole blood. We analyzed 336 cryopreserved specimens from adult Ugandans with sepsis enrolled in a multisite study; 84% were infected with human immunodeficiency virus. We compared qPCR TAC results with blood culture and determined the association of qPCR with study participant outcomes using logistic regression.
Results: The most frequently detected targets were cytomegalovirus (CMV, n = 139, 41%), Mycobacterium tuberculosis (TB, n = 70, 21%), Plasmodium (n = 35, 10%), and Streptococcus pneumoniae (n = 31, 9%). Diagnostic performance varied by target with qPCR sensitivity averaging 61 ± 28% and specificity 98 ± 3% versus culture. In multivariable analysis, independent factors associated with in-hospital mortality included CMV viremia (adjusted odds ratio [aOR] 3.2, 95% confidence interval [CI], 1.8-5.5; p < .01) and TB qPCR-positivity, whether blood culture-positive (aOR 4.6, 95% CI, 2.1-10.0; p < .01) or blood culture-negative (aOR 2.9, 95% CI, 1.2-6.9; p = .02). Conclusions: Using qPCR TAC on direct blood specimens, CMV and TB were the most commonly identified targets and were independently associated with increased in-hospital mortality. qPCR TAC screening of blood for multiple targets may be useful to guide triage and treatment of sepsis in sub-Saharan Africa.

Entities:  

Mesh:

Year:  2019        PMID: 29868873      PMCID: PMC6321855          DOI: 10.1093/cid/ciy472

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  41 in total

1.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.

Authors:  Anand Kumar; Daniel Roberts; Kenneth E Wood; Bruce Light; Joseph E Parrillo; Satendra Sharma; Robert Suppes; Daniel Feinstein; Sergio Zanotti; Leo Taiberg; David Gurka; Aseem Kumar; Mary Cheang
Journal:  Crit Care Med       Date:  2006-06       Impact factor: 7.598

2.  Assessment of viable bacteria and bacterial DNA in blood and bloodstain specimens stored under various conditions.

Authors:  Junji Hosokawa-Muto; Yoshihito Fujinami; Natsuko Mizuno
Journal:  J Forensic Leg Med       Date:  2013-10-09       Impact factor: 1.614

3.  Q fever, spotted fever group, and typhus group rickettsioses among hospitalized febrile patients in northern Tanzania.

Authors:  Malavika Prabhu; William L Nicholson; Aubree J Roche; Gilbert J Kersh; Kelly A Fitzpatrick; Lindsay D Oliver; Robert F Massung; Anne B Morrissey; John A Bartlett; Jecinta J Onyango; Venance P Maro; Grace D Kinabo; Wilbrod Saganda; John A Crump
Journal:  Clin Infect Dis       Date:  2011-08       Impact factor: 9.079

Review 4.  Accuracy of LightCycler(®) SeptiFast for the detection and identification of pathogens in the blood of patients with suspected sepsis: a systematic review and meta-analysis.

Authors:  Paul Dark; Bronagh Blackwood; Simon Gates; Danny McAuley; Gavin D Perkins; Ronan McMullan; Claire Wilson; Daniel Graham; Kate Timms; Geoffrey Warhurst
Journal:  Intensive Care Med       Date:  2014-11-22       Impact factor: 17.440

Review 5.  Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit.

Authors:  Andre C Kalil; Diana F Florescu
Journal:  Crit Care Med       Date:  2009-08       Impact factor: 7.598

6.  Leptospirosis and human immunodeficiency virus co-infection among febrile inpatients in northern Tanzania.

Authors:  Holly M Biggs; Renee L Galloway; Duy M Bui; Annie B Morrissey; Venance P Maro; John A Crump
Journal:  Vector Borne Zoonotic Dis       Date:  2013-05-10       Impact factor: 2.133

7.  Cytomegalovirus reactivation in ICU patients.

Authors:  Laurent Papazian; Sami Hraiech; Samuel Lehingue; Antoine Roch; Laurent Chiche; Sandrine Wiramus; Jean-Marie Forel
Journal:  Intensive Care Med       Date:  2015-09-30       Impact factor: 17.440

8.  Severe sepsis in two Ugandan hospitals: a prospective observational study of management and outcomes in a predominantly HIV-1 infected population.

Authors:  Shevin T Jacob; Christopher C Moore; Patrick Banura; Relana Pinkerton; David Meya; Pius Opendi; Steven J Reynolds; Nathan Kenya-Mugisha; Harriet Mayanja-Kizza; W Michael Scheld
Journal:  PLoS One       Date:  2009-11-11       Impact factor: 3.240

9.  Evaluation of Xpert MTB/RIF for detection of tuberculosis from blood samples of HIV-infected adults confirms Mycobacterium tuberculosis bacteremia as an indicator of poor prognosis.

Authors:  Nicholas A Feasey; Padmapriya P Banada; William Howson; Derek J Sloan; Aaron Mdolo; Catharina Boehme; Geoffrey A Chipungu; Theresa J Allain; Robert S Heyderman; Elizabeth L Corbett; David Alland
Journal:  J Clin Microbiol       Date:  2013-05-15       Impact factor: 5.948

10.  Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa.

Authors:  Andrew A Adjei; Henry B Armah; Foster Gbagbo; Isaac Boamah; Clement Adu-Gyamfi; Isaac Asare
Journal:  BMC Infect Dis       Date:  2008-08-18       Impact factor: 3.090

View more
  21 in total

1.  Simultaneous detection of multiple pathogens with the TaqMan Array Card.

Authors:  Rachael Lappan; Thanavit Jirapanjawat; Deborah A Williamson; Sigrid Lange; Steven L Chown; Chris Greening
Journal:  MethodsX       Date:  2022-04-20

2.  Multiple pathogens contribute to human immunodeficiency virus-related sepsis in addition to Mycobacterium tuberculosis: A prospective cohort in Tanzania.

Authors:  Donatus Bonphace Tsere; Gabriel Mkilema Shirima; Brian S Grundy; Scott K Heysell; Stellah G Mpagama; Shabani Ramadhani Mziray; Peter M Mbelele
Journal:  Int J Mycobacteriol       Date:  2022 Jul-Sep

3.  Effect of Empiric Anti-Mycobacterium tuberculosis Therapy on Survival Among Human Immunodeficiency Virus-Infected Adults Admitted With Sepsis to a Regional Referral Hospital in Uganda.

Authors:  Riley H Hazard; Peninah Kagina; Richard Kitayimbwa; Keneth Male; Melissa McShane; Dennis Mubiru; Emma Welikhe; Christopher C Moore; Amir Abdallah
Journal:  Open Forum Infect Dis       Date:  2019-03-14       Impact factor: 3.835

4.  Aetiology and outcomes of sepsis in adults in sub-Saharan Africa: a systematic review and meta-analysis.

Authors:  Joseph M Lewis; Nicholas A Feasey; Jamie Rylance
Journal:  Crit Care       Date:  2019-06-11       Impact factor: 9.097

5.  Development and Implementation of Multiplex TaqMan Array Cards for Specimen Testing at Child Health and Mortality Prevention Surveillance Site Laboratories.

Authors:  Maureen H Diaz; Jessica L Waller; M Jordan Theodore; Nishi Patel; Bernard J Wolff; Alvaro J Benitez; Timothy Morris; Pratima L Raghunathan; Robert F Breiman; Cynthia G Whitney; Dianna M Blau; Jonas M Winchell
Journal:  Clin Infect Dis       Date:  2019-10-09       Impact factor: 9.079

6.  Etiology of Pediatric Meningitis in West Africa Using Molecular Methods in the Era of Conjugate Vaccines against Pneumococcus, Meningococcus, and Haemophilus influenzae Type b.

Authors:  Brenda A Kwambana-Adams; Jie Liu; Catherine Okoi; Jason M Mwenda; Nuredin I Mohammed; Enyonam Tsolenyanu; Lorna Awo Renner; Daniel Ansong; Beckie N Tagbo; Muhammad F Bashir; Mamadou Kourna Hama; Mouhamadou A Sonko; Jean Gratz; Archibald Worwui; Peter Ndow; Adam L Cohen; Fatima Serhan; Richard Mihigo; Martin Antonio; Eric Houpt
Journal:  Am J Trop Med Hyg       Date:  2020-05-21       Impact factor: 2.345

7.  Paenibacillus infection with frequent viral coinfection contributes to postinfectious hydrocephalus in Ugandan infants.

Authors:  Joseph N Paulson; Brent L Williams; Christine Hehnly; Nischay Mishra; Shamim A Sinnar; Lijun Zhang; Paddy Ssentongo; Edith Mbabazi-Kabachelor; Dona S S Wijetunge; Benjamin von Bredow; Ronnie Mulondo; Julius Kiwanuka; Francis Bajunirwe; Joel Bazira; Lisa M Bebell; Kathy Burgoine; Mara Couto-Rodriguez; Jessica E Ericson; Tim Erickson; Matthew Ferrari; Melissa Gladstone; Cheng Guo; Murali Haran; Mady Hornig; Albert M Isaacs; Brian Nsubuga Kaaya; Sheila M Kangere; Abhaya V Kulkarni; Elias Kumbakumba; Xiaoxiao Li; David D Limbrick; Joshua Magombe; Sarah U Morton; John Mugamba; James Ng; Peter Olupot-Olupot; Justin Onen; Mallory R Peterson; Farrah Roy; Kathryn Sheldon; Reid Townsend; Andrew D Weeks; Andrew J Whalen; John Quackenbush; Peter Ssenyonga; Michael Y Galperin; Mathieu Almeida; Hannah Atkins; Benjamin C Warf; W Ian Lipkin; James R Broach; Steven J Schiff
Journal:  Sci Transl Med       Date:  2020-09-30       Impact factor: 17.956

8.  Population Pharmacokinetics and Significant Under-Dosing of Anti-Tuberculosis Medications in People with HIV and Critical Illness.

Authors:  Prakruti S Rao; Christopher C Moore; Amir A Mbonde; Edwin Nuwagira; Patrick Orikiriza; Dan Nyehangane; Mohammad H Al-Shaer; Charles A Peloquin; Jean Gratz; Suporn Pholwat; Rinah Arinaitwe; Yap Boum; Juliet Mwanga-Amumpaire; Eric R Houpt; Leonid Kagan; Scott K Heysell; Conrad Muzoora
Journal:  Antibiotics (Basel)       Date:  2021-06-18

Review 9.  Addressing advanced HIV disease and mortality in global HIV programming.

Authors:  Andrew T Boyd; Ikwo Oboho; Heather Paulin; Hammad Ali; Catherine Godfrey; Anand Date; J Sean Cavanaugh
Journal:  AIDS Res Ther       Date:  2020-07-10       Impact factor: 2.250

10.  Presentation and outcome of suspected sepsis in a high-HIV burden, high antiretroviral coverage setting.

Authors:  Wendy Chaka; Christopher Berger; Stella Huo; Valerie Robertson; Chipo Tachiona; Marcelyn Magwenzi; Trish Magombei; Chengetai Mpamhanga; David Katzenstein; John Metcalfe
Journal:  Int J Infect Dis       Date:  2020-04-11       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.